News

Video

Easing a Hospital Stay for a Patient With Cancer as an Oncology Nurse

Author(s):

Jessica McDade, B.S.N., RN, OCN, explains how she helps make her patients’ experience “a little less daunting” during their hospital stay.

One oncology nurse explained how her personal experience with cancer in her family has shaped her to be a source of support for patients with cancer.

Jessica McDade, B.S.N, RN, OCN, who is a charge nurse at the Dana-Farber Cancer Institute in Boston, was a finalist for the 2024 Extraordinary Healer® Award for oncology nursing. In an interview with CURE® ahead of the ceremony, she discussed how she has been on both sides of the cancer experience —as an oncology nurse and as a caregiver to family members with cancer.

She explained how seemingly small things, such as advice about how to pay for parking nearby hotels, can “take a little bit of weight off somebody’s shoulders.”

“It's an easy thing that I can do, but it really could make somebody else's life [easier],” McDade said.

Nominations are now open for the 2025 CURE Extraordinary Healer award.

Transcript

I think that would be somebody [who] makes a patient's stay a little less daunting.

I've been on the other side of the bed — both as a daughter and as a mother — and having those people there to guide you [who] have experienced that, have seen it before and [to] give you resources and reassurance is more than you could ever ask for. So even if I just have one little bit of advice, even if it's just how to pay for parking or what hotel to stay at, just to take a little bit of the weight off of somebody's shoulders. It's an easy thing that I can do, but it really could make somebody else's life [easier].

For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.

Related Videos
Image of Dr. Fakih.
.Dr. Catherine Wu, chief of the Division of Stem Cell Transplantation and Cellular Therapies at Dana-Farber Cancer Institute, and institute member at the Broad Institute of MIT and Harvard, in Boston
Image of Doctor with blonde hair.
Dr. Katy Beckermann discusses how a Fotivda and Opdivo combination for renal cell carcinoma compared with Fotivda alone based on patient feedback.
Dr. Petros Grivas discusses what precautions should be considered when treating patients with advanced urothelial carcinoma who have diabetes.
Dr. Debu Tripathy discussed the importance of understanding the distinctions between HER2-low and HER2-ultralow breast cancer.
Primary urothelial cancer has variable histologies, making its treatment complex, leading to varied outcomes with high rates of recurrence in patients.
Dr. Neeraj Agarwal is a medical oncologist, a professor of medicine and the Presidential Endowed Chair of Cancer Research at the Huntsman Cancer Institute, University of Utah, as well as director of the Genitourinary Oncology Program and the Center of Investigational Therapeutics at the Huntsman Cancer Institute in Salt Lake City.
Image of Dr. Goy.
Image of bald man.
Related Content